Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Focal Therapy Using High Intensity Focused Ultrasound (ABLATHERM®) for Localised Prostate Cancer

NCT02016040 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT02016040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Focal Therapy Using High Intensity Focused Ultrasound (ABLATHERM®) for Localised Prostate Cancer
Lead sponsor
Jewish General Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 17, 2013
Completion date
November 30, 2017
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer